Endometrial Carcinoma: Better Prognosis for Asymptomatic Recurrences Than for Symptomatic Cases Found by Routine Follow-up

Overview

Journal Int J Clin Oncol

Specialty Oncology

Date 2010 Apr 29

PMID 20425132

Citations 3

Authors

Yutaka Ueda

Takayuki Enomoto

Tomomi Egawa-Takata

Takashi Miyatake

Kiyoshi Yoshino

Masami Fujita

Shinya Matsuzaki

Takuhei Yokoyama

Yukari Miyoshi

Tadashi Kimura

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to determine if there is a prognostic value for the presence of symptoms at the time of recurrence detection in surgically resected endometrial carcinoma patients.

Methods: During the study period of 2000-2006, complete surgical removal of endometrial carcinoma was achieved in 271 stage I-IV endometrial cancer cases at the Department of Obstetrics and Gynecology of Osaka University Hospital, Osaka, Japan. A subsequent recurrence was detected in 29 (11%) of these cases. Patient characteristics and clinicopathological features were retrospectively reviewed utilizing their clinical records.

Results: Among the 29 cases with a recurrence, 13 (45%) had symptoms, whereas in the other 16 cases (55%) the recurrent disease was found only during routine follow-up procedures. Although the time to detection of recurrence was similar for both asymptomatic and symptomatic cases, progression-free survival after detection in the 16 asymptomatic patients was significantly longer than for the 13 symptomatic patients (P = 0.017); this was found to be especially true in those who underwent chemotherapy as their adjuvant therapy (P = 0.023).

Conclusions: A better prognosis after recurrence was demonstrated in cases that were asymptomatic at the time of recurrence detection than in those in which the tumor was symptomatic. This finding implies that, after the initial surgical resection, intensive follow-up intervention looking for asymptomatic recurrences may significantly improve the prognosis of endometrial carcinoma patients. A further in-depth prospective study is required to establish a standard strategy of follow-up care for endometrial cancer patients.

Citing Articles

Reassessment of intensive surveillance practices adopted for endometrial cancer survivors.

Nakamura K, Kitahara Y, Yamashita S, Kigure K, Ito I, Nishimura T BMC Womens Health. 2022; 22(1):355.

PMID: 35999573 PMC: 9396785. DOI: 10.1186/s12905-022-01937-1.

How Do We Follow Up Patients With Endometrial Cancer?.

Jeppesen M, Mogensen O, Hansen D, Bergholdt S, Jensen P Curr Oncol Rep. 2019; 21(7):57.

PMID: 31093835 DOI: 10.1007/s11912-019-0805-3.

Trial of Optimal Personalised Care After Treatment for Gynaecological cancer (TOPCAT-G): a study protocol for a randomised feasibility trial.

Pye K, Totton N, Stuart N, Whitaker R, Morrison V, Tudor Edwards R Pilot Feasibility Stud. 2016; 2:67.

PMID: 27965882 PMC: 5154014. DOI: 10.1186/s40814-016-0108-5.

References

Salvesen H, Akslen L, Iversen T, Iversen O . Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol. 1997; 104(11):1302-7. DOI: 10.1111/j.1471-0528.1997.tb10979.x. View

Randall M, Filiaci V, Muss H, Spirtos N, Mannel R, Fowler J . Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2005; 24(1):36-44. DOI: 10.1200/JCO.2004.00.7617. View

Elit L, Fyles A, Devries M, Oliver T, Fung-Kee-Fung M . Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol. 2009; 114(3):528-35. DOI: 10.1016/j.ygyno.2009.06.001. View

Keys H, Roberts J, Brunetto V, Zaino R, Spirtos N, Bloss J . A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004; 92(3):744-51. DOI: 10.1016/j.ygyno.2003.11.048. View

Berchuck A, Anspach C, Evans A, Soper J, Rodriguez G, Dodge R . Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol. 1995; 59(1):20-4. DOI: 10.1006/gyno.1995.1262. View

Ng T, Ngan H, Cheng D, Wong L . Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful?. Aust N Z J Obstet Gynaecol. 1997; 37(1):104-6. DOI: 10.1111/j.1479-828x.1997.tb02229.x. View

Reddoch J, Burke T, Morris M, Tornos C, Levenback C, Gershenson D . Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995; 59(2):221-5. DOI: 10.1006/gyno.1995.0012. View

Morice P, Levy-Piedbois C, Ajaj S, Pautier P, Haie-Meder C, Lhomme C . Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer. 2001; 37(8):985-90. DOI: 10.1016/s0959-8049(01)00066-1. View

Creutzberg C, van Putten W, Koper P, Lybeert M, Jobsen J, Warlam-Rodenhuis C . Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000; 355(9213):1404-11. DOI: 10.1016/s0140-6736(00)02139-5. View

10.

Aalders J, Abeler V, KOLSTAD P, Onsrud M . Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980; 56(4):419-27. View

11.

Piver M, Yazigi R, Blumenson L, Tsukada Y . A prospective trail comparing hysterectomy, hysterectomy plus vaginal radium, and uterine radium plus hysterectomy in stage I endometrial carcinoma. Obstet Gynecol. 1979; 54(1):85-9. DOI: 10.1097/00006250-197907000-00020. View

12.

Podczaski E, Kaminski P, Gurski K, MacNeill C, Stryker J, Singapuri K . Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol. 1992; 47(3):323-7. DOI: 10.1016/0090-8258(92)90134-5. View

13.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani A . An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res. 2000; 20(3B):1977-84. View

14.

Agboola O, Grunfeld E, Coyle D, Perry G . Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ. 1997; 157(7):879-86. PMC: 1228212. View

15.

Gordon A, Owen P, Chien P, Duncan I . A critical evaluation of follow-up of women treated for endometrial adenocarcinoma. J Obstet Gynaecol. 1997; 17(4):386-9. DOI: 10.1080/01443619750112952. View

16.

Shumsky A, Stuart G, Brasher P, Nation J, Robertson D, Sangkarat S . An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol. 1994; 55(2):229-33. DOI: 10.1006/gyno.1994.1282. View

17.

Owen P, Duncan I . Is there any value in the long term follow up of women treated for endometrial cancer?. Br J Obstet Gynaecol. 1996; 103(7):710-3. DOI: 10.1111/j.1471-0528.1996.tb09843.x. View

18.

Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T . Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol. 2006; 101(3):520-9. DOI: 10.1016/j.ygyno.2006.02.011. View